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Abstract
Background Robotically assisted colon resection is a new
type of surgery for colon cancer. However, the evidence is
inadequate for the general adaptation of robotic colon
surgery. This study aimed to show the oncologic and per-
ioperative clinical results of robotically assisted anterior
resection (R-AR) compared with those of laparoscopically
assisted anterior resection (L-AR) for sigmoid colon
cancer.
Methods A total of 180 patients (sigmoid colon cancer
stages 1–3) were assigned to receive either R-AR (n = 34)
or L-AR (n = 146) between April 2006 and September
2008. Patient characteristics, perioperative clinical results,
and long-term oncologic outcomes were compared between
the two groups.
Results The patient characteristics did not differ signifi-
cantly between the two groups. The mean operation time
was 217.6 ± 70.7 min for L-AR versus 252.5 ± 94.9 min
for R-AR (p = 0.016). The total postoperative complica-
tion rate was 10.3 % for R-AR versus 5.9 % for L-AR
(p = 0.281). The 3-year overall survival rate for all the
patients was 93.4 % for L-AR versus 92.1 % for R-AR
(p = 0.723). The 3-year overall survival rate was 100 %
for both L-AR and R-AR in stage 1, 95.5 % for L-AR
versus 100 % for R-AR (p = 0.386) in stage 2, and 88.4 %
for L-AR versus 72.9 % (p = 0.881) for R-AR in stage 3.
Conclusion In this study, R-AR showed safety and fea-
sibility in terms of perioperative clinical and long-term
oncologic outcomes. However, the advanced technologies
of R-AR did not translate into better long-term oncologic
outcomes compared with L-AR.
Keywords Minimally invasive surgery  Robotic surgery 
Sigmoid colon cancer
Laparoscopically assisted colectomy has been accepted as
a safe minimally invasive procedure since several large-
scale randomized clinical trials reported the oncologic
safety and better short-term outcomes compared with those
of open surgery [1–3].
Robotically assisted colectomy, introduced by Weber
and coworker [4] in 2001, can be understood as a new
variation of laparoscopic surgery because the robotic sys-
tem uses video laparoscopy and pneumoperitoneum, which
are similar in nature to conventional laparoscopic surgery.
However, the robotic system has several advanced tech-
nologies compared with conventional laparoscopic surgery.
The technological advantages of the robotic system are a
three-dimensional surgical view using a stable camera
platform, fine and free movements of the robotic arm in the
surgical fields, tremor elimination, motion scaling, dex-
terity, and ambidextrous capability [5, 6]. It has been
interesting to observe how these advanced robotic tech-
nologies affect the short- and long-term outcomes of colon
cancer surgery compared with conventional laparoscopic
surgery.
Reports from several case series have described the
feasibility and safety of robotic surgery for colon cancer
[5–9]. However, to date, comparative results in terms of
long-term oncologic outcomes after robotic surgery for
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colon cancer are scarce. This study aimed to evaluate the
long-term oncologic outcomes and perioperative short-term
clinical outcomes compared with the results of conven-
tional laparoscopic surgery for colon cancer.
Materials and methods
Between April 2006 and December 2008, 334 sigmoid
colon cancer patients (stages 1–3 adenocarcinoma) under-
went a curative anterior resection at Severance Hospital,
Yonsei University, Seoul, South Korea. Of these 334
patients, 180 consecutive patients with a diagnosis of sig-
moid colon cancer underwent curative minimally invasive
surgery, which included laparoscopically assisted anterior
resection (L-AR, n = 146) and robotically assisted anterior
resection (R-AR, n = 34) using the da Vinci surgical
system (Intuitive Surgical, Sunnyvale, CA, USA), and 154
patients underwent open surgery according to the decision
of the patient with his or her informed consent. This study
enrolled 180 patients who underwent either L-AR or R-AR.
The data were collected prospectively from the Yonsei
Colorectal Cancer Database. The perioperative clinical
results and oncologic outcomes were compared retrospec-
tively between the L-AR group and the R-AR group. The
oncologic data were updated again for the current study
using electronic medical charts and telephone interviews.
Patient characteristics, American Society of Anesthesi-
ologists (ASA) score [10], history of previous abdominal
surgeries, and body mass index (BMI) were evaluated. The
criteria for discharge specified no apparent complications,
no abnormal physical examination findings, no subjective
complaints, and tolerance of a soft diet.
Postoperative complications were categorized using the
Accordion severity-grading system [11]. Conversion was
defined as the need for a laparotomy exceeding the routine
length of an incision for specimen extraction (4 cm) at any
time to complete the entire surgical procedure.
For the postoperative pathologic results, tumor node
metastasis (TNM) stage (American Joint Committee on
Cancer [AJCC] 6th) [12], grade of tumor differentiation,
distal and proximal resection margins, and number of
harvested lymph nodes were evaluated. Recurrence was
defined as the presence of radiologically confirmed or
histologically proven tumor. Follow-up assessments of the
patients were performed routinely at 1, 3 months, and then
every 3 months until 3 years and every 6 months until
5 years. Chest and abdominopelvic computed tomography
(CT) scan were used for local detection or systemic
recurrence every 6 months.
This study was approved by the Institutional Review
Board of Severance Hospital, and informed consent was
obtained from all the patients.
Surgical technique of laparoscopically assisted anterior
resection
A standard mechanical bowel preparation was performed
24 h before the operation. The patient was placed in a
modified lithotomy position with the legs apart. After
achievement of pneumoperitoneum (pressure, 12 mmHg), a
12-mm trocar was placed through an incision just above the
umbilicus. A 30 laparoscope then was inserted through the
12-mm trocar. The second 12-mm trocar was inserted at the
lower right quadrant of the abdomen. The third 5-mm trocar
was inserted at the upper right quadrant of the abdomen. The
fourth and fifth 5-mm trocars were inserted at the upper and
the lower left quadrants. The patient then was placed in a
modified lithotomy position with the legs apart in a 30
Trendelenburg position with the right side down at 15o.
After ligation of the inferior mesenteric artery and vein,
medial-to-lateral dissection is performed to the left lateral gut-
ter. The sigmoid colon itself was divided using an endo-GIA
(Covidien Echelon). The specimen was extracted though the
left lower trocar incision, which was enlarged to *3–4 cm,
after protection. An end-to-end anastomosis (EEA) anvil then
was inserted into the proximal colon and secured with a purse-
string suture. The colon was placed back into the abdomen, and
the port site was closed. Pneumoperitoneum was restored, and a
circular stapler was used to create an end-to-end anastomosis.
Surgical technique of robotically assisted anterior
resection
After induction of general anesthesia, the patient was placed
in a modified lithotomy position with the legs apart. A 12-mm
trocar was placed through an incision just below the umbili-
cus after achievement of pneumoperitoneum. A 30 standard
12-mm robotic laparoscope then was inserted through the
12-mm trocar. The first 8-mm da Vinci trocar was placed in
the middle point on the line between the infraumbilical
12-mm trocar and the right anterior superior iliac supine. The
second 8-mm da Vinci trocar was inserted into the right upper
abdomen. The third 8-mm da Vinci trocar was inserted 2 cm
below the xiphoid process. The 11-mm trocar was placed in
the right midabdomen lateral to the umbilicus and 3 cm lat-
eral from the midaxillary line to allow access of the assistant
for mobilization of the left colon. The remainder of the pro-
cedure was the same as in laparoscopic surgery except for the
specimen extraction site and the infraumblilical trocar, which
was enlarged to 3–4 cm. An EEA was used in both the lap-
aroscopic and robotic procedures.
Statistical analysis
Data were analyzed using the SPSS statistical program
(Statistical Product and Service Solution 18 for Windows;
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SPSS Inc., Chicago, IL, USA). The Chi-square test for
categorical variables and the Student’s t test or the Mann–
Whitney test for continuous variables were used for sta-
tistical comparisons of perioperative clinical outcomes.
Cumulative-incidence methods were used to estimate the
rate of cancer recurrence. Overall survival and disease-free
survival were analyzed using the Kaplan–Meier method,
and a comparison was performed using the log-rank test.
Converted cases were considered on an intention-to-treat
basis. All p values lower than 0.05 were considered sta-
tistically significant.
Results
Patient characteristics
In this study, 146 patients underwent L-AR, and 34 patients
underwent R-AR. The following parameters were evalu-
ated as the characteristics of the patients: age, sex, weight,
height, mean BMI, ASA score, tumor location from the
anal verge, and operation history. None of these parameters
differed significantly between the groups (Table 1).
Perioperative clinical outcomes and complications
The mean operating time was 217.6 ± 70.7 min (95 %
confidence interval [CI], 205.6–229.1 min) in the L-AR
group and 252.5 ± 94.9 min (95 % CI, 219.3–285.6 min)
in the R-AR group (p = 0.016). The hemoglobin change
did not differ significantly between the two groups
(p = 0.546). Days to first gas passing and stool passing,
days to soft diet, and days of hospitalization were statisti-
cally fewer in the R-AR group than in the L-AR group.
The L-AR group had one case of conversion compared
with no conversions in the R-AR group. The reason for the
conversion in the L-AR group was intraoperative bleeding
due to an injury in the left renal vein.
The overall postoperative complication rate during
fewer than 30 postoperative days was 10.3 % in the L-AR
group and 5.9 % in the R-AR group (p = 0.281). The rate
for severe complications requiring reoperation was 1.4 %
in the L-AR group and 0 % in the R-AR group.
Readmission occurred for one patient each in the L-AR
and the R-AR groups. The reason for readmission was ileus
in both groups. There were no mortality cases in either
group (Table 2).
Postoperative pathologic results
The distribution of the TNM stage and the histologic grade
of differentiation did not differ significantly between the
two groups. The mean number of harvested lymph nodes
was 16.5 ± 11.3 in the L-AR group and 12.0 ± 7.9 in the
R-AR group (p = 0.031). The mean proximal resection
margin was 8.2 ± 2.9 cm in the L-AR group and
10.7 ± 3.4 cm in the R-AR group (p = 0.026). The mean
distal resection margin and the mass size did not differ
significantly between the two groups (Table 3).
Oncologic outcomes
The mean follow-up period was 36.9 ± 11.8 months
(range, 2–63 months). The 3-year overall survival rate for
the all the patients was 93.5 % in the L-AR group and
92.1 % in the R-AR group (p = 0.723). The 3-year dis-
ease-free survival rate for all the patients was 90.9 % in the
L-AR group and 89.2 % in the R-AR group (p = 0.890)
Table 1 Patient characteristics
(n = 180)
BMI body mass index, ASA
American Society of
Anesthesiologists
Laparoscopic anterior
resection (n = 146)
Robotic anterior
resection (n = 34)
p value
Mean age: years (range) 59.7 ± 11.5 (29–90) 59.6 ± 8.4 (41–77) 0.969
Sex: n (%) 0.439
Male 87 (59.6) 23 (67.6)
Female 59 (40.4) 11 (32.4)
Mean weight: kg (range) 63.3 ± 11.9 (37–113) 66.7 ± 10.0 (48–93) 0.123
Mean height: cm (range) 163 ± 8 (135–184) 164 ± 9 (146–185) 0.481
Mean BMI: kg/m2 (range) 23.8 ± 3.8 (16.0–39.1) 24.8 ± 2.1 (20.8–29.4) 0.135
ASA score: n (%) 0.134
1 107 (73.3) 19 (55.9)
2 33 (22.6) 13 (38.2)
3 6 (4.1) 2 (1.4) 0.931
Mean tumor location from anal
verge: cm (range)
25.9 ± 7.1 (13–50) 22.2 ± 7.2 (10–40)
Previous operation history: n (%) 25 (17.1) 4 (11.7) 0.606
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(Fig. 1). The 3-year overall and disease-free survival rate
for the stage 1 patients was 100 % in both groups. The
3-year overall and disease-free survival rate for the stage 2
patients was 91.3 % in the L-AR group and 100 % in the
R-AR group (p = 0.298) (Fig. 2A). The 3-year overall
survival rate for the stage 3 patients was 88.9 % in the
L-AR group and 72.9 % in the R-AR group (p = 0.557).
The 3-year disease-free survival rate for the stage 3 patients
was 80.1 % in the L-AR group and 72.9 % in the R-AR
group (p = 0.454) (Fig. 2D).
Discussion
The data from the study showed the feasibility and safety
of R-AR, with oncologic and perioperative outcomes
similar to those of L-AR. The mean operation time was
significantly longer in the R-AR group than in the L-AR
group. The short-term outcomes of this study showed
patterns similar to those of previous published studies [8, 9,
13, 14].
During the postoperative course, the amount of intra-
operative bleeding did not differ significantly between the
R-AR and L-AR groups. However, the clinical parameters
related to a fast recovery. The days to first gas passing, the
days to first stool passing, the days to soft diet, and the days
of hospitalization were significantly fewer in the R-AR
group than in the L-AR group. These results showed a
pattern similar to that in our previous report [6].
Core advanced technologies of the robotic system may
have had a positive influence in the R-AR group. Rela-
tively lower complication rates in the R-AR group than in
the L-AR group also may be positively related to the
technological advantages of the robotic system, although
the difference was not statistically significant. Conse-
quently, the relatively lower complication rates in the
R-AR group may shorten the hospital stay, the time to first
gas passing, and the time to first stool passing. However,
the exact cause for the shorter hospital stay and lower
complication rate cannot be assessed based on the study
design.
Rawlings et al. [7] reported systematically on the
advantages of robotic surgery including a view magnified
tenfold, the surgeon’s control over the camera, seven
degrees of freedom of the instrument tips, and reduced
fatigue of the surgeon. These advantages may help to
Table 2 Perioperative clinical outcomes and postoperative complications
Laparoscopic anterior
resection (n = 146)
Robotic anterior
resection (n = 34)
p value
Perioperative clinical outcomes
Mean total operation time: min (range) 217.6 ± 70.7 (82–400) 252.5 ± 94.9 (117–460) 0.016
Mean intraoperative bleeding: ml (range) 78.2 ± 12.3 (0–600) 60.3 ± 27.0 (0–800) 0.772
Mean time to 1st gas passing: days (range) 2.52 ± 0.8 (1–5) 2.21 ± 0.9 (1–5) 0.040
Mean time to 1st stool passing: days (range) 4.42 ± 0.9 (2–7) 3.85 ± 0.2 (2–7) 0.003
Mean time to soft diet:days (range) 5.2 ± 1.3 (3–16) 4.5 ± 1.2 (2–7) 0.009
Mean hospital stay: (range) 6.2 ± 1.3 (4–17) 5.5 ± 1.6 (3–8) 0.005
Conversion
Postoperative complications: n (%)
Mild complications
Chyloperitoneum 4 (2.7) 0 (0)
Ileus 1 (0.7) 2 (5.9)
Wound infection 2 (1.4) 0 (0)
Voiding difficulty 5 (3.4) 0 (0)
Moderate complications
Pneumonia 0 (0) 0 (0)
Postoperative bleeding 1 (0.7) 0 (0)
Severe complications
Intraabdominal abscess 0 (0) 0 (0)
Anastomotic leakage 2 (1.4) 0 (0)
Deaths (30-day mortality) 0 (0) 0 (0)
Total no. of complications 15 (10.3) 2 (5.9) 0.281
Total no. of patients with complications 15 (10.3) 2 (5.9) 0.281
Readmission due to complications 1 (0.7) 1 (2.9) 0.258
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obtain better short-term clinical or long term oncologic
outcomes than laparoscopically assisted surgery. However,
a view magnified tenfold may not be necessary in the large
surgical field for performing an anterior resection for sig-
moid colon cancer. The surgeon’s control over the camera
with a stable camera platform in robotic surgery can be
compensated with an experienced camera holder in lapa-
roscopic surgery. Two additional degrees of freedom of
robotic instrument tips also can be compensated by proper
traction and retraction of the redundant colon during
mobilization of the colon.
The aforementioned considerations imply that a minimally
invasive surgery expert can overcome the technological
advantages of the robotic system by just using conventional
laparoscopic instruments. The current generation of the robotic
system has no voluntary action or decision and mimics the
surgeon’s hand motion. This fact is the main reason for the
difficulty evaluating the objective efficacy of the robotic system.
The 3-year overall survival and the 3-year disease-free
survival of the R-AR group did not differ with those of the
L-AR group. The oncologic outcomes according to the
stages of R-AR showed results similar to those of the R-AR
group.
The oncologic safety of laparoscopic colon surgery for
cancer has been proven by large multicenter randomized
clinical trials [1–3]. In these clinical trials, the oncologic
results were comparable with those of open surgery. This
implies that the resection range of laparoscopic colon
surgery for cancer did not differ from that of open proce-
dure in terms of resection margins, lymph node dissection,
or any iatrogenic tissue injury of the resected specimen.
In the same manner, the quality of the resected specimen
did not differ between the R-AR and L-AR groups in this
study. The concepts of standard oncologic resection depend
on the range of resection [15]. Thus, it cannot differ among
open, laparoscopic, and robotic procedures. However, in
this study, the total number of harvested lymph nodes was
lower in the R-AR group and the proximal resection mar-
gin longer in the R-AR group than in the L-AR group.
Table 3 Postoperative pathologic outcomes
Laparoscopic
anterior
resection
(n = 146)
Robotic
anterior
resection
(n = 34)
p value
TNM stage: n (%) 0.185
1 52 (35.6) 14 (41.2)
2 36 (24.7) 12 (35.3)
3 58 (39.7) 8 (23.5)
T stage: n (%) 0.954
1 38 (26.0) 9 (26.5)
2 24 (16.4) 5 (14.7)
3 78 (53.4) 19 (55.9)
4 6 (4.1) 1 (2.9)
N stage: n (%) 0.233
0 89 (61.0) 26 (76.5)
1 48 (32.9) 7 (20.6)
2 9 (6.1) 1 (2.9)
Mean harvested lymph
nodes: n (range)
All stage 16.5 ± 11.3
(2–56)
12.0 ± 7.9
(1–31)
0.031
Stage 1 13.1 ± 11.9
(2–56)
7.7 ± 5.8
(1–21)
0.080
Stage 2 18.2 ± 8.8
(5–46)
15.5 ± 8.4
(3–26)
0.404
Stage 3 18.5 ± 11.5
(4–52)
14.4 ± 8.1
(5–46)
0.387
Mean PRM: cm (range) 8.2 ± 2.9
(3–19)
10.7 ± 3.4
(3.5–35)
0.026
Mean DRM: cm (range) 4.9 ± 2.8
(1–25)
5.4 ± 3.4
(1–20)
0.452
TNM tumor node metastasis, PRM proximal margin, DRM distal
margin
A 
B 
L-AR (146) = 93.5% 
p=0.735 
p=0.873 
L-AR (146) = 90.0% 
R-AR (34) = 89.2% 
R-AR (34) = 92.1% 
Fig. 1 The 3-year overall (A) and 3-year disease-free (B) survival
rates
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The total number of harvested lymph nodes is related to
understaging and poor oncologic outcomes [16]. In this
study, the relatively small number of harvested lymph
nodes in the R-AR group was not translated as poor
oncologic outcomes compared with the L-AR group. The
difference in the number of harvested lymph nodes may
have been related to a type 2 statistical error considering
the small number of cases in the R-AR group and the same
resection range of both the robotic and the laparoscopic
procedures. Further large-scale comparative studies are
necessary to solve this issue.
The robotic system has several disadvantages despite its
many advanced technological advantages. The robotic
system has no tactile sense. Thus, all instruments should be
moved very precisely and carefully in the small surgical
field generated by the camera to prevent dangerous injuries
around the site. Moreover, the operator cannot know the
power of holding the tissue and the tension of traction or
countertraction during the procedure. Just a visual cue can
compensate for this disadvantage.
These disadvantages can be related to the longer oper-
ation time in the R-AR group compared with that in the
L-AR group in this study because fast instrument move-
ment and movement around the site are possible with the
laparoscopic procedure, which has tactile sense. Docking
time of robotic instruments and disengagement can be
A B
C D
R-AR (12) = 100% 
892.0=p892.0=p
R-AR (12) = 100% 
L-AR (36) = 91.3% 
p=0.557 p=0.454 
R-AR (8) = 72.9% 
L-AR (58) = 88.9% L-AR (58) = 80.1% 
L-AR (36) = 91.3% 
R-AR (8) = 72.9% 
Fig. 2 The 3-year overall and disease-free survival rates according to stage. A 3-year overall survival for stage 2. B 3-year disease-free survival
for stage 2. C 3-year overall survival for stage 3 D 3-year disease-free survival for stage 3
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another explanation for the longer operation time in the
R-AR group. Similarly, with this study, Rawlings et al.
[17] reported a longer operation time for the robotic pro-
cedure than for the laparoscopic procedure although the
data did not reach statistical significance. However, the
operation time difference of 35 min on the average
(*14 % of the operation length) can be considered non-
significant for a 4-h operation in this study.
Conclusion
Compared with L-AR, R-AR was technically safe and
feasible and had similar oncologic safety and perioperative
outcomes. No extra-significant morbidity or mortality was
noted in the R-AR group. However, the high cost might be
a further debatable issue for general adaption of R-AR.
This study had a potential selection bias because ran-
domization was not performed and the study had a retro-
spective case–control design. Thus, future large-scale
randomized clinical trials and objective cost-effectiveness
analysis should evaluate the efficacy of robotically assisted
colon surgery.
Acknowledgments This study was supported by a faculty research
Grant of Yonsei University College of Medicine (No. 6-2011-0114).
Disclosures Dae Ro Lim, Byung Soh Min, Min Sung Kim, Sami
Alasari, Gangmi Kim, Hyuk Hur, Seung Hyuk Baik, Kang Young
Lee, and Nam Kyu Kim have no conflicts of interest or financial ties
to disclose.
Open Access This article is distributed under the terms of the
Creative Commons Attribution License which permits any use, dis-
tribution, and reproduction in any medium, provided the original
author(s) and the source are credited.
References
1. Jayne DG, Thorepe H, Copeland J et al (2010) Five-year follow-
up of the Medical Research Council CLASICC trial of laparo-
scopically assisted versus open surgery for colorectal cancer. Br J
Surg 97:1638–1645
2. Clinical Outcomes of Surgical Therapy Study Group (2004) A
comparison of laparoscopically assisted and open colectomy for
colon cancer. N Engl J Med 350:2050–2059
3. The Colon Cancer Laparoscopic or Open Resection Study Group
(2009) Survival after laparoscopic surgery versus open surgery
for colon cancer: long-term outcome of a randomized clinical
trial. Lancet Oncol 10:44–52
4. Ballantyne GH, Merola P, Weber A et al (2001) Robotic solutions
to the pitfalls of laparoscopic colectomy. Osp Ital Chir 7:405–412
5. D’Annibale A, Morpurgo E, Fiscon V et al (2004) Robotic and
laparoscopic surgery for treatment of colorectal diseases. Dis
Colon Rectum 47:2162–2168
6. Baik SH, Kwon HY, Kim JS et al (2009) Robotic versus lapa-
roscopic low anterior resection of rectal cancer: short-term out-
come of a prospective comparative study. Ann Surg Oncol 16:
1480–1487
7. Rawlings AL, Woodland JH, Crawford DL (2006) Telerobotic
surgery for right and sigmoid colectomies: 30 consecutive cases.
Surg Endosc 20:1713–1718
8. deSouza SL, Prasad LM, Park JJ, Marecik SJ, Blumetti J,
Abcarian H (2010) Robotic assistance in right hemicolectomy: is
there a role? Dis Colon Rectum 53:1000–1006
9. Huettner F, Pacheco PE, Doubet JL, Ryan MJ, Dynda DI,
Crawford DL (2011) One hundred and two consecutive robotic-
assisted minimally invasive colectomies-an outcome and techni-
cal update. J Gastrointest Surg 15:1195–1204
10. Owens WD, Felts JA, Spitznagel EL Jr (1978) ASA physical
status classifications: a study of consistency of ratings. Anes-
thesiology 49:239–243
11. Strasberg SM, Linehan DC, Hawkins WG (2009) The Accordion
severity grading system of surgical complications. Ann Surg
250:177–186
12. American Joint Committee on Cancer (2002) AJCC cancer
staging manual, 6th edn. Springer, New York
13. Choi GS, Park IJ, Kang BM, Lim KH, Jun SH (2009) A novel
approach of robotic-assisted anterior resection with transanal or
transvaginal retrieval of the specimen for colorectal cancer. Surg
Endosc 23:2831–2835
14. Antoniou SA, Antoniou GA, Koch OO, Pointner R, Granderath
FA (2012) Robotic-assisted laparoscopic surgery of the colon and
rectum. Surg Endosc 26:1–11
15. Compton CC, Fielding LP, Burgart LJ, Conley B, Cooper HS,
Hamilton SR et al (2000) Prognostic factors in colorectal cancer.
College of American Pathologists Consensus Stagement 1999.
Arch Pathol Lab Med 124:979–994
16. Chang GJ, Rodriquez-Bigas MA, Skibber JM, Moyer VA (2007)
Lymph node evaluation and survival after curative resection of
colon cancer: systemic review. J Natl Cancer Inst 99:433–434
17. Rawlings AL, Woodland JH, Vegunta RK, Crawford DL (2007)
Robotic versus laparoscopic colectomy. Surg Endosc 21:1701–1708
Surg Endosc (2013) 27:1379–1385 1385
123
